We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Identifying Gene Interactions Through Single-Cell Imaging

By LabMedica International staff writers
Posted on 04 Mar 2010
Cellular imaging provides a huge amount of data about how cells respond to stimuli, but harnessing this technique to study biologic systems is an overwhelming challenge. More...
In a recent study, researchers have developed an innovative method of interpreting data from single-cell images to identify genetic interactions within biologic networks, offering a glimpse into the future of high-throughput cell imaging analysis.

For years, scientists have been looking through a microscope at cells as they change appearance in response to different treatments, yet data collection is time-consuming, largely conducted qualitatively by eye. However, recent technologic developments have led to the development of high-throughput image screening methods that can produce extensive datasets of hundreds of different morphologic features.

With the ability to collect large imaging datasets, researchers from the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) and Harvard Medical School (Boston, MA, USA) recognized an opportunity to explore the cellular networks that regulate cell morphology. "These images are an enormous source of data that is only beginning to be tapped,” said MIT researcher Dr. Bonnie Berger, senior author of the study, which was published online in February 9, 2010, in the journal Genome Research. "We realized we had enough data to go beyond classification and start to understand the mechanism behind the differences in shape.”

To meet the challenge of interpreting cell image data, Dr. Berger and MIT graduate student Oaz Nir developed an innovative computational model to identify genetic interactions using high-dimensional morphologic data. The model, integrating prerequisite knowledge of a pathway, maps potential interactions within a network by looking for similar morphologic characteristics upon genetic perturbation.

The group demonstrated the method by analyzing the Rho-signaling network in fruit flies, a network that regulates cell adhesion and motility in eukaryotic organisms. In collaboration with Dr. Chris Bakal and Dr. Norbert Perrimon at Harvard Medical School, they "knocked-down” components of the Rho-signaling network using RNA interference and then imaged thousands of fly cells, collecting measurements of cell perimeter, nuclear area, and more than 150 other morphologic features for each cell. The data were then passed through the computational framework to generate a set of high-confidence interactions, supported by confirmation of previously known interactions.

The investigators discovered that by making combinatorial knockdowns of Rho network components, their computational method was able to accurately infer Rho-signaling network interactions more precisely than when using only data from single knockdowns. Dr. Berger noted that this finding highlights the importance of combinatorial experiments for inferring complex networks, necessary to overcome natural redundancy in signaling pathways. As perturbation of the Rho pathway in humans has been implicated in cancer and other diseases, the scientists believe that these predicted interactions will be excellent candidates for future study.

Dr. Berger expects that in combination with other sources of data, imaging as a new source of high-throughput data should appreciably increase the accuracy of known signaling networks. "This work provides a glimpse into the future,” added Dr. Berger, "where looking under the microscope manually at cells one-by-one is replaced with automated high-throughput processing of many cellular images.”

Related Links:
Massachusetts Institute of Technology
Harvard Medical School


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.